OrthoPediatrics Corp.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- David R. Bailey
- Full Time Employees
- 602
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 2850 Frontier Drive Warsaw IN United States of America 46582
- IPO Date
- Oct 13, 2017
- CIK
- 0001425450
- Website
- orthopediatrics.com
- Similar Companies
- Business
- OrthoPediatrics Corp. is a medical technology enterprise dedicated to the design, development, and commercialization of specialized implants, instruments, and bracing solutions tailored for children confronting orthopedic conditions across the United States and internationally. The company provides a broad range of offerings encompassing trauma and deformity correction, comprehensive scoliosis management including spinal growth guidance systems, and sports medicine procedures. Key product lines include various nailing platforms such as PediNail and PediFlex nail, plate systems like PediPlates, cannulated screws, and advanced solutions such as RESPONSE Spine systems, ApiFix Mid-C System, and the recently introduced VerteGlide Spinal Growth Guidance System. Additionally, its OrthoPediatrics Specialty Bracing (OPSB) division expands its non-surgical solutions. Serving the distinct pediatric orthopedic market, the company partners with pediatric orthopedic surgeons and caregivers. Founded in 2006, OrthoPediatrics Corp. maintains its headquarters in Warsaw, Indiana.
Company News
Intercontinental Exchange Reports August 2026 Statistics
ICE First Look at Mortgage Performance: Mortgage Delinquencies Ease in July as Both New Defaults and Cure Activity Improve
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter
Intercontinental Exchange Reports July 2026 Statistics
OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript
OrthoPediatrics Q2 Earnings Call Highlights
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates
OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance
Intercontinental Exchange Approves Third Quarter Dividend of $0.52 per Share
Intercontinental Exchange to Acquire MarketAxess, Creating a Premier Fixed Income Marketplace
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
ICE First Look at Mortgage Performance: New Default Activity Posts Annual Decline Led by FHA Loans
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
ICE Mortgage Monitor: Gen Z Accounts for Record 1 in 5 Purchase Mortgage Locks
Intercontinental Exchange Reports June and Second Quarter 2026 Statistics
POTTERY BARN KIDS LAUNCHES NEW COLLABORATION WITH RYLEE + CRU
POTTERY BARN KIDS LAUNCHES NEW COLLABORATION WITH BRIA HAMMEL
OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children's Hospitals Nationwide
OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript